Before treatment
Know when to pause. Know when to get help.
A clear name, a checkable source, and clear instructions all belong in the conversation before treatment.
When to get urgent help.
Difficulty breathing or swelling of the tongue may signal a severe allergic reaction.
If allergy symptoms are severe, call 911 or go directly to an emergency room.
Evidence for this chapter
- MedlinePlus: severe allergic reactions
MedlinePlus guidance, checked on September 17, 2026, lists tongue swelling and difficulty breathing among the possible signs of a severe allergic reaction.
Pause when the offer avoids a clear answer.
Federal law, as checked on September 26, 2026, prohibited dispensing prescription medicine without a valid prescription.
The Food and Drug Administration is the US agency that checks medicines; FDA is its short name.
Compounded means a medicine is made to order. It is false to say that medicine has FDA approval, as checked on September 26, 2026.
In its July 2026 bulletin, Washington’s Pharmacy Commission said research-labelled ingredients cannot be used in medicines compounded for patients.
The bulletin explains existing rules; it does not create a new law.
FDA also found labels that named pharmacies which did not exist, as recorded September 26, 2026.
Ask for the pharmacy’s full name and check it in the state record before accepting a vague answer.
Find the Washington licence checkEvidence for this chapter
- FDA: misleading labels and care offers
As of September 26, 2026, FDA warned about false approval claims and labels naming pharmacies that did not exist.
- Washington: Pharmacy Commission guidance
The linked state page holds the July 2026 compounding bulletin.
Get product-specific answers before using anything.
Some peptide medicines need to be kept in a fridge; others can stay at room temperature.
Ask the pharmacist what the label requires and what to do if a delivery arrives in the wrong condition.
GLP-1 medicines copy a signal that helps the body manage blood sugar and appetite.
If an injectable GLP-1 medicine is warm on arrival or has been kept too warm, FDA says not to use it.
By September 26, 2026, reports sent to FDA described harm among people using semaglutide prepared to order for injection. Some people needed hospital care. Errors in measuring how much medicine to inject may have played a part.
If the instructions do not make sense, ask your prescriber or pharmacist to explain. Do not use a web guide to calculate how much medicine to draw into a syringe.
As of September 26, 2026, FDA raised concerns about the body reacting to several peptide ingredients used in injections. For these ingredients, little or no information about safety in people was available.
The body may treat an ingredient as an invader and react against it. This is called an immune reaction.
Evidence for this chapter
- FDA: delivery and measuring concerns
Storage and measuring concerns are product-specific; they do not establish a rule for every peptide.
- FDA: concerns about peptide ingredients
As of September 26, 2026, FDA had little or no safety information from people for several of these ingredients.
Keep a record and find the right reporting route.
Keep the label, messages, receipts, and a clear timeline if you have a concern.
Patients can send medicine-problem reports directly to FDA through MedWatch.
Open FDA MedWatchIn Washington, complaints about medical doctors (MDs) and physician assistants go to the Medical Commission.
Medical Commission complaint routeNurse and nurse practitioner complaints go to the state nursing board.
Nursing board complaint routeFor pharmacy concerns and complaints about most other health roles, use the health department’s process.
Health department complaint routeEvidence for this chapter
- FDA: product reporting
Reporting a concern is separate from seeking care for it.
- Washington: the complaint process
The state reporting routes were checked September 30, 2026.